Medicines Australia welcomes Morrison Government Ministry

Medicines Australia welcomes the appointment of the Morrison Government Ministry following the May 18 Federal Election.

With the recent confirmation that Prime Minister the Hon Scott Morrison MP will lead a majority government and today’s appointment of an experienced Ministry, Medicines Australia looks forward to working with members of the Ministry to provide stability and continuity for the continued investment of the innovative pharmaceutical sector and the research and development capabilities of Australia.

Medicines Australia CEO Elizabeth de Somer said: “In particular, Medicines Australia is delighted to see the continuation of the Hon Greg Hunt MP in the health portfolio as Minister for Health. Prime Minister Morrison has made the right call in keeping the critical portfolio of Health in the capable hands of Minister Hunt, as we continue to implement the improvements agreed under the 2017 Strategic Agreement, streamline processes and reduce delays in access to new and breakthrough medicines.

“Medicines Australia has enjoyed a positive working relationship with Minister Hunt, and we welcome the opportunity to reinforce our important work together to ensure the prompt implementation and delivery on the commitments made to the sector during their election campaign. This includes a review of the National Medicines Policy, long-awaited Clinical Trial reform, and reduced listing times and processes,” said Ms de Somer.

Medicines Australia also congratulates Senator the Hon Karen Andrews for her re-appointment as the Minister for Industry, Science and Technology, the Hon Ken Wyatt MP for his promotion to the portfolio of Minister for Indigenous Australians and Senator the Hon Simon Birmingham on his reappointment as Minister for Trade, Tourism and Investment.

“With a strong and stable government, including the reappointment of Ministers in central economic portfolios, such as Treasury and Finance, Medicines Australia looks forward to ensuring strong investment in the medicines that matter to all Australians, that keep patients out of hospital and contributing to the economic health and wealth of Australia,” said Ms de Somer.


More information – Natalie Wimmer – Communications Manager – 0450 728 660